50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
NASDAQ:LEGN

Legend Biotech - LEGN Earnings Date, Estimates & Call Transcripts

$40.11
-0.25 (-0.62%)
(As of 09/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$39.54
$40.37
50-Day Range
$38.35
$50.50
52-Week Range
$30.75
$58.00
Volume
394,289 shs
Average Volume
716,793 shs
Market Capitalization
$6.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$66.80
Skip Charts & View Estimated and Actual Earnings Data

LEGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LEGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Legend Biotech Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20222($0.49)($0.42)($0.46)
Q2 20222($0.72)($0.45)($0.59)
Q3 20222($0.78)($0.46)($0.62)
Q4 20222($0.76)($0.51)($0.64)
FY 20228($2.75)($1.84)($2.30)
Q1 20231($0.49)($0.49)($0.49)
Q2 20231($0.54)($0.54)($0.54)
Q3 20231($0.57)($0.57)($0.57)
Q4 20231($0.62)($0.62)($0.62)
FY 20234($2.22)($2.22)($2.22)

LEGN Earnings Date and Information

Legend Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 3rd, 2022 based off prior year's report dates.

Legend Biotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
10/3/2022
(Estimated)
        
6/1/2022Q1 2022($0.37)($0.24)+$0.13($0.35)$46.67 million$40.83 million
3/18/2022Q4 2021($0.35)($0.38)($0.03)($0.46)$13.23 million$39.00 million
11/16/20219/30/2021($0.35)($0.43)($0.08)($0.43)$12.50 million$16.88 million
8/22/20216/30/2021($0.34)($0.64)($0.30)($0.31)$12.50 million$20.23 million
5/17/20213/31/2021($0.35)($0.30)+$0.05($0.30)$12.50 million$13.68 million
3/17/202112/31/2020($0.28)($0.22)+$0.06($0.22)$12.88 million$40.78 million  
11/15/20209/30/2020($0.31)($0.50)($0.19)($0.25)$12.80 million$11.75 million
8/28/2020Q2 2020($0.26)($0.26)$0.11$12.78 million$11.60 million












Legend Biotech Earnings - Frequently Asked Questions

When is Legend Biotech's earnings date?

Legend Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 3rd, 2022 based off last year's report dates. Learn more on LEGN's earnings history.

How much revenue does Legend Biotech generate each year?

Legend Biotech (NASDAQ:LEGN) has a recorded annual revenue of $89.79 million.

How much profit does Legend Biotech generate each year?

Legend Biotech (NASDAQ:LEGN) has a recorded net income of -$386.21 million. LEGN has generated -$1.19 earnings per share over the last four quarters.

What is Legend Biotech's EPS forecast for next year?

Legend Biotech's earnings are expected to decrease from ($2.31) per share to ($2.77) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:LEGN) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.